Bone Sarcomas: From Molecular Mechanisms to Therapies Strategies
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: closed (31 March 2022) | Viewed by 454
Special Issue Editors
Interests: bone and soft tissue sarcomas; rare tumors; melanoma
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Primary bone sarcomas are extremely rare tumors accounting for less than 0.2% of all cancers. In adults, over 40% of primary bone cancers are chondrosarcomas. This is followed by osteosarcomas (28%), chordomas (10%), Ewing tumors (8%), and malignant fibrous histiocytoma/fibrosarcomas (4%). The remainder of cases are several even more rare types of bone cancers. Both osteosarcoma and Ewing sarcoma occur most often in children and teens (younger than 20 years) where they represent 56% and 34%, respectively, of the diagnosis of bone sarcomas.
Primary bone sarcomas demonstrate wide clinical heterogeneity. High-grade bone sarcomas require intensive treatment due to their rapid and invasive growth pattern, and although intensive chemotherapy and establishment of surgical procedures have improved the outcomes of patients with sarcoma, the curative rate of recurrent and metastatic sarcomas is still not satisfactory. Because of this rarity and heterogeneity, the development of adequately powered clinical trials has been moreover a challenge. Consequently, the treatment landscape has evolved little in the last decade and novel therapies are urgently needed, particularly in the metastatic setting.
The aim of this special issue is to highlight the advances in the treatment for bone sarcomas with particular attention to the elucidation of new biological pathways and molecular alterations as potential therapeutic targets.
Dr. Virginia Ferraresi
Prof. Dr. Sabrina Vari
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Osteosarcoma
- Ewing Sarcoma
- Condrosarcoma
- Cordoma
- “Histotype bone STM”
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
